glp-1 euglycemic dka Life-Saving Awareness: Recognizing and Preventing Ketoacidosis in Patients on SGLT-2 and Therapy Frontiers | Glucagon-like peptide-1 receptor

Non-fluorinated pyrrolidine analogs are found to be less potent than their fluorinated counterparts

Lower blood volume means your heart works harder to deliver oxygen to tissues

But I do know, Ive heard from patients that a big concern is: will biosimilars have the same type of support programs that biologics do

If changes emerge shortly after starting the medication or increasing the dose and improve when the dose is reduced that suggests the medication may be contributing

Imagine if we still had Blockbuster stores, but every single store in your town was out-of-stock of a movie because the demand was THAT high

These reports raised concerns, but so far larger studies and FDA evaluations have not confirmed a clear increase in risk